11 Jul 2019 07:00
Collagen Solutions Plc
(the "Company")
Director/PDMR Dealing
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that 2,500,000 options ("Options") over the ordinary shares of 1p each in the share capital of the Company ("Ordinary Shares") were granted to Directors and Persons Discharging Managerial Responsibilities on 10 July 2019.
The Options, which will vest in three equal tranches over three years, have an exercise period of ten years from grant and have an exercise price per Option of 3.85p. The Options vest in full upon the closing middle market price per Ordinary Share achieving 10p and positive cash flows from operations being sustained for any period of six months following date of grant.
Director/PDMR | Position | Number of Ordinary Shares options granted
|
Lou Ruggiero | Chief Business Officer | 1,000,000 |
Kevin Darling | PDMR / VP Tissue Products | 750,000 |
Chris Wattengel | PDMR / VP Global R&D | 750,000 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||||
a)
| Name
| 1. Lou Ruggiero 2. Kevin Darling 3. Christian Wattengel | ||||||||
2
| Reason for the notification
| |||||||||
a)
| Position/status
| 1. Chief Business Officer 2. PDMR / VP Tissue Products 3. PDMR / VP Global R&D | ||||||||
b)
| Initial notification /Amendment
| Initial notification | ||||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||||
a)
| Name
| Collagen Solutions plc | ||||||||
b)
| LEI
| 213800IFY1CVGRGETL95 | ||||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 1p each
ISIN Code: GB00B94T6Y14
| ||||||||
b)
| Nature of the transaction
| Grant of options over ordinary shares of 1p each exercisable at 3.85p | ||||||||
c)
| Price(s) and volume(s)
|
| ||||||||
d)
| Aggregated information
- Aggregated volume
- Price
|
2,500,000
N/a
| ||||||||
e)
| Date of the transaction
| 10 July 2019 | ||||||||
f)
| Place of the transaction
| Outside a trading venue | ||||||||
Enquiries:
Collagen Solutions Plc | Contact via Walbrook | ||
Jamal Rushdy, Chief Executive Officer |
| ||
Hilary Spence, Chief Financial Officer |
| ||
|
| ||
Cenkos Securities plc (Nominated Adviser and Broker) |
| ||
Giles Balleny | Tel: 0207 397 8900 | ||
Stephen Keys |
| ||
|
| ||
Walbrook PR | Tel: 020 7933 8780 or collagen@walbrookpr.com | ||
Anna Dunphy | Mob: 07876 741 001 | ||